Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders
- 31 March 1996
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 34 (3), 470-481
- https://doi.org/10.1016/s0190-9622(96)90442-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomasBritish Journal of Dermatology, 2008
- Lymphomatoid papulosisJournal of the American Academy of Dermatology, 1994
- Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatmentJournal of the American Academy of Dermatology, 1993
- Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis.A European multicenter study of 47 patientsCancer, 1993
- Lymphomatoid papulosis expresses immunophenotypes associated with T cell lymphoma but not inflammationJournal of the American Academy of Dermatology, 1986
- Atypical Cells in Lymphomatoid Papulosis Express the Hodgkin Cell-Associated Antigen Ki-1Journal of Investigative Dermatology, 1986
- The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsBlood, 1985
- The clinical and histological spectrum of lymphomatoid papulosisBritish Journal of Dermatology, 1982
- LYMPHOMATOID PAPULOSISInternational Journal of Dermatology, 1978
- Lymphomatoid PapulosisArchives of Dermatology, 1968